“The American Heart Council is a Non-Profit Organization dedicated to promoting an awareness of non-surgical Cardiovascular treatment methods. The American Heart Council supports and endorses non-surgical methods, that have been proven and shown effective through clinical studies and customer use. While we do endorse companies and their products, the Council does not make claims for the products or the Companies.” (http://americanheartcouncil.com/About.asp; accessed 7/6/05)
The American Heart Council endorses a single product: Angioprim, which is made by Ionetics Corporation, a wholly owned subsidiary of GMC Holdings Corporation. (“GMC Holdings Announces a 3 for 1 Forward Split for Shareholders as of March 10th, 2002,” Business Wire, March 1, 2002, Friday) The vast majority of the American Heart Council webpage is devoted to discussing the merits of Angioprim.
The Council’s webpage, www.americanheartcouncil.com, is registered to Slocumb and Associates (now Central Marketing Solutions), and Jack Slocumb is the administrative contact and technical contact. (http://www.networksolutions.com/en_US/whois/results.jhtml;jsessionid= SDFNNAXKQIWPKCWMEAQCFFA?whoistoken=23&_requestid=876425; accessed 7/8/05) Jack Slocumb is listed as a representative on the Angioprim website. (http://angioprim.com/Home/Contact.asp?RepID=10001&Home=Y; accessed 7/8/05)
In 2005, the FDA issued a warning to Ionetics Corporation stating that Angioprim, which has never been approved by the FDA, is a drug under the Federal Food, Drug, and Cosmetic Act because its labeling claims that Angioprim “is intended for use in the cure, mitigation, treatment, or prevention of disease.” The FDA letter then lists specific claims from the websites associated with Angioprim that violate the Act. (http://www.fda.gov/foi/warning_letters/g5223d.htm; accessed 7/6/05)
According to the National Council Against Health Fraud, the drug websites mentioned in the FDA’s warning letter have not been corrected. They still contain the offending claims about the efficacy of Angioprim. (http://www.ncahf.org/digest05/05-12.html; accessed 7/6/05)
(See also the American Diabetes Council)